Literature DB >> 7799798

Determination of adenylyl cyclase catalytic activity using single and double column procedures.

R A Johnson1, R Alvarez, Y Salomon.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7799798     DOI: 10.1016/0076-6879(94)38005-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  14 in total

1.  Inhibition of adenylyl cyclase by neuronal P2Y receptors.

Authors:  Ursula Unterberger; Eugenia Moskvina; Thomas Scholze; Michael Freissmuth; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Activation of muscarinic acetylcholine receptors via their allosteric binding sites.

Authors:  J Jakubík; L Bacáková; V Lisá; E E el-Fakahany; S Tucek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Second-messenger regulation of receptor association with clathrin-coated pits: a novel and selective mechanism in the control of CD4 endocytosis.

Authors:  M Foti; J L Carpentier; C Aiken; D Trono; D P Lew; K H Krause
Journal:  Mol Biol Cell       Date:  1997-07       Impact factor: 4.138

4.  Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.

Authors:  P Michal; M Lysíková; S Tucek
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 5.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

6.  Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder.

Authors:  D Marazziti; S Baroni; L Palego; I Masala; G Consoli; M Catena Dell'osso; G Giannaccini; A Lucacchini
Journal:  Neuropsychiatr Dis Treat       Date:  2009-07-02       Impact factor: 2.570

7.  Mice with deficiency of G protein gamma3 are lean and have seizures.

Authors:  William F Schwindinger; Kathryn E Giger; Kelly S Betz; Anna M Stauffer; Elaine M Sunderlin; Laura J Sim-Selley; Dana E Selley; Sarah K Bronson; Janet D Robishaw
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Attenuation of the P2Y receptor-mediated control of neuronal Ca2+ channels in PC12 cells by antithrombotic drugs.

Authors:  Helmut Kubista; Stefan G Lechner; Angelika M Wolf; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.

Authors:  Shahrooz Nasrollahi-Shirazi; Daniel Szöllösi; Qiong Yang; Edin Muratspahic; Ali El-Kasaby; Sonja Sucic; Thomas Stockner; Christian Nanoff; Michael Freissmuth
Journal:  Mol Pharmacol       Date:  2020-09       Impact factor: 4.436

10.  The cox-2-specific inhibitor celecoxib inhibits adenylyl cyclase.

Authors:  Shamsher S Saini; Deborah L Gessell-Lee; Johnny W Peterson
Journal:  Inflammation       Date:  2003-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.